QUENTIS THERAPEUTICS
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.
QUENTIS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.quentistx.com
Total Employee:
11+
Status:
Active
Contact:
(646) 440-9249
Email Addresses:
[email protected]
Total Funding:
49 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail PHP GoDaddy DNS Gravatar Profiles Sectigo SSL Sectigo Domain SSL Unified Layer
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Comet Therapeutics
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
scibac
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
Current Advisors List
Founder
Investors List
New York City Economic Development Corporation - NYCEDC
New York City Economic Development Corporation - NYCEDC investment in Grant - Quentis Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Quentis Therapeutics
Versant Ventures
Versant Ventures investment in Series A - Quentis Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Quentis Therapeutics
New York Ventures
New York Ventures investment in Series A - Quentis Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Quentis Therapeutics
Taiho Pharmaceutical Co
Taiho Pharmaceutical Co investment in Series A - Quentis Therapeutics
Yonghua Capital
Yonghua Capital investment in Series A - Quentis Therapeutics
Official Site Inspections
http://www.quentistx.com
- Host name: box5634.bluehost.com
- IP address: 162.241.219.101
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Quentis Therapeutics"
Quentis Therapeutics - Crunchbase Company Profile
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to …See details»
Quentis Therapeutics, Inc Overview | SignalHire Company Profile
Organization Website: quentistx.com : Social Links: Phone Number: 646-440-9249: Quentis Therapeutics... industries Biotech, Biotechnology: Headquarters Location: 430 E 29th St, New …See details»
Quentis Therapeutics, Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Quentis Therapeutics, Inc of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Quentis Therapeutics - PitchBook
Quentis Therapeutics General Information Description. Developer of immuno-therapeutics designed to translate novel biology into new therapeutic approaches. The company's …See details»
Quentis Therapeutics - Overview, News & Similar companies
May 16, 2018 Quentis Therapeutics contact info: Phone number: (646) 440-9249 Website: www.quentistx.com What does Quentis Therapeutics do? Quentis Therapeutics is a preclinical …See details»
Quentis Therapeutics - VentureRadar
"Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from …See details»
Quentis Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 430 E 29th St Suite 1005. New York, New York, 10016, United States. 646-440-9249See details»
Quentis Therapeutics - Company Profile - Tracxn
Feb 27, 2025 Quentis Therapeutics - Developer of therapies for treating cancer and neurodegenerative diseases. This company is not active anymore. Raised a total funding of …See details»
Quentis Therapeutics - Craft
Quentis Therapeutics has 5 employees at their 1 location and $48 m in total funding,. See insights on Quentis Therapeutics including office locations, competitors, revenue, financials, …See details»
Quentis Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Aug 4, 2023 Explore Quentis Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Quentis Therapeutics - Funding, Financials, Valuation & Investors
In funding over 2 rounds. Their latest funding was raised on Dec 3, 2018 from a Grant round. Quentis Therapeutics is funded by 8 investors. New York City Economic Development …See details»
Quentis Therapeutics Inc Overview | Salary.com
Discover essential details about Quentis Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Quentis - CoBee Company Profile & Funding Rounds
Quentistx.com Quentis. Quentis is a biotechnology company that engages in the immuno-oncology research and drug development for the treatment of cancer. Business Model: …See details»
Quentis’s Competitors, Revenue, Number of Employees, Funding …
Quentis’s Profile, Revenue and Employees. Quentis is a biotechnology company that engages in the immuno-oncology research and drug development for the treatment of cancer. Quentis’s …See details»
Quentis Therapeutics Company Profile: Overview and Full News …
Quentis Therapeutics is a biotechnology company based in New York that specializes in developing innovative therapies for various diseases. The company focuses on leveraging …See details»
NYC-Based Quentis Therapeutics is Named a "Fierce 15" Biotech …
NEW YORK, Oct. 2, 2018 /PRNewswire/ -- Quentis Therapeutics, Inc., a biotechnology company developing therapies that target endoplasmic reticulum (ER) stress pathways, today …See details»
Quentistx.com - Home - Quentis Therapeutics... Traffic, Ranking ...
Quentistx.com receives about 296 unique visitors per day, and it is ranked 4,013,554 in the world. quentistx.com uses Apache, Google Font API, WordPress, jQuery Migrate, PHP, MySQL, …See details»
Quentis Therapeutics-动脉网
[email protected] Quentis Therapeutics是一家生物技术公司，Quentis处于下一代免疫肿瘤学公司的最前沿，这些公司正在将新型生物学转化为新的治疗方法，以帮助更多患者从免疫疗法中 …See details»
Quentis Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Quentis Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Quentis Therapeutics Announces the Appointment of Jeanne
May 16, 2018 NEW YORK--(BUSINESS WIRE)-- Quentis Therapeutics Inc., a biotechnology company pursuing first-in-class endoplasmic reticulum (ER) stress response-targeted …See details»